← Back to Patent Explorer
US4778793A Expired / Lapsed US ⏱️ 0.0 years remaining

Dihydroquinolinone derivatives, processes for their preparation, medicaments containing them and their use, and intermediate products for their preparation

Assignee: Hoechst AG
•
Filing: 1986-07-18
•
Granted: 1988-10-18
•
Expires: 2006-07-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula I ##STR1## where R(1), R(2), R(3), R(4) and R(5) are, inter alia, hydrogen and alkyl, m is 1-4, n is 0 or 1, p is 0-4 and R(6) is identical or different dialkylamine derivatives, and salts thereof, have a calcium-antagonistic action. They are obtained by reacting corresponding amines with a compound II which carries, on the side chain, a leaving group which can be displaced nucleophilically, or from a hydroxyphenyl-dihydroquinolin-2-one compound by reaction with a corresponding side chain compound which has a leaving group which can be displaced nucleophilically.

Inventors

  • 👤 Rainer Henning
  • 👤 Ulrich Lerch
  • 👤 Joachim Kaiser

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 08:20
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/22; C07D215/227; A; A61; A61P; A61P3/00; A61P3/12; A61P3/14; A61P9/00; C07D401/00; C07D401/02; C07D401/12

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 479 words
A compound of the formula I ##STR51## in which R(1), R(1)' and R(1)" are identical or different and independent of one another and denote hydrogen, (C 1 -C 4 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , nitro, hydroxyl, acetamido or amino, or R(1) and R(1)' together denote (C 1 -C 2 )-alkylenedioxy, R(2) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl or straight-chain or branched (C 3 -C 10 )-alkenyl, R(3) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl, straight-chain or branched (C 3 -C 10 )-alkenyl, (C 4 -C 8 )-cycloalkyl, (C 4 -C 8 )-cycloalkyl-(C 1 -C 4 )-alkyl or phenyl-(C 1 -C 4 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three substituents from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , (C 1 -C 2 )-alkylenedioxy and nitro, R(4) and R(4)' are identical or different and independently of one another denote hydrogen, (C 1 -C 4 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , nitro, hydroxyl, acetamido or amino, R(5) denotes hydrogen, hydroxyl or (C 1 -C 3 )-alkyl, m denotes 1, 2, 3 or 4, n denotes 0 or 1, p denotes 0, 1, 2, 3 or 4 and R(6) denotes one of the following groups ##STR52## in which R(7) and R(8) are identical or different and independently of one another denote hydrogen, (C 1 -C 10 )-alkyl, (C 4 -C 8 )-cycloalkyl, (C 4 -C 8 )-cycloalkyl-(C 1 -C 4 )-alkyl, phenyl-(C 1 -C 6 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl-C 1 -C 4 )-alkyl, R(9) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl or diphenyl-(C 1 -C 5 )-alkyl, phenyl-(C 1 -C 4 )-alkanoyl, benzoyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl, pyrimidinyl or (C 1 -C 5 )-alkanoyl, R(10) denotes hydrogen, (C 1 -C 10 )-alkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl and hydroxyl, R(11) denotes hydrogen, hydroxyl or (C 1 -C 4 )-alkoxy, or together with R(12) denotes a bond, and R(12) denotes hydrogen, or together with R(11) denotes a bond; and the salts of the compounds of the formula I with pharmaceutically acceptable acids.
Claim 2
Dependent Claim 479 words
A compound of the formula I ##STR51## in which R(1), R(1)' and R(1)" are identical or different and independent of one another and denote hydrogen, (C 1 -C 4 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , nitro, hydroxyl, acetamido or amino, or R(1) and R(1)' together denote (C 1 -C 2 )-alkylenedioxy, R(2) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl or straight-chain or branched (C 3 -C 10 )-alkenyl, R(3) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl, straight-chain or branched (C 3 -C 10 )-alkenyl, (C 4 -C 8 )-cycloalkyl, (C 4 -C 8 )-cycloalkyl-(C 1 -C 4 )-alkyl or phenyl-(C 1 -C 4 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three substituents from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , (C 1 -C 2 )-alkylenedioxy and nitro, R(4) and R(4)' are identical or different and independently of one another denote hydrogen, (C 1 -C 4 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , nitro, hydroxyl, acetamido or amino, R(5) denotes hydrogen, hydroxyl or (C 1 -C 3 )-alkyl, m denotes 1, 2, 3 or 4, n denotes 0 or 1, p denotes 0, 1, 2, 3 or 4 and R(6) denotes one of the following groups ##STR52## in which R(7) and R(8) are identical or different and independently of one another denote hydrogen, (C 1 -C 10 )-alkyl, (C 4 -C 8 )-cycloalkyl, (C 4 -C 8 )-cycloalkyl-(C 1 -C 4 )-alkyl, phenyl-(C 1 -C 6 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl-C 1 -C 4 )-alkyl, R(9) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl or diphenyl-(C 1 -C 5 )-alkyl, phenyl-(C 1 -C 4 )-alkanoyl, benzoyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl, pyrimidinyl or (C 1 -C 5 )-alkanoyl, R(10) denotes hydrogen, (C 1 -C 10 )-alkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl and hydroxyl, R(11) denotes hydrogen, hydroxyl or (C 1 -C 4 )-alkoxy, or together with R(12) denotes a bond, and R(12) denotes hydrogen, or together with R(11) denotes a bond; and the salts of the compounds of the formula I with pharmaceutically acceptable acids.
Claim 3
Dependent Claim 364 words
A compound I as claimed in claim 1, wherein PG,47 R(1) and R(1)' are identical or different and independently of one another denote hydrogen, methyl, ethyl, methoxy, ethoxy, fluorine, chlorine, CF 3 , nitro or acetamido; R(1)" denotes hydrogen, p1 R(2) denotes hydrogen or straight-chain or branched (C 1 -C 6 )-alkyl, R(3) denotes hydrogen, straight-chain or branched (C 1 -C 6 )-alkyl, allyl, cyclopentyl, cyclohexyl, benzyl or phenethyl, in each case unsubstituted or substituted by (C 1 -C 3 )-alkyl, (C 1 -C 3 )-alkoxy, F, Cl, CF 3 , (C 1 -C 2 )-alkylenedioxy or nitro, R(4) denotes hydrogen, methyl, methoxy, ethoxy, chlorine, nitro, hydroxyl, acetamido or amino, R(4)' denotes hydrogen, R(5) denotes hydrogen or hydroxyl, m denotes 1, 2 or 3, n denotes 0 or 1, p denotes 1, 2, 3 or 4 and R(6) denotes one of the following groups ##STR53## in which R(7) denotes hydrogen, methyl, ethyl, propyl or isopropyl, R(8) denotes hydrogen, methyl, ethyl, propyl, isopropyl, cyclopentylethyl, cyclohexylethyl, phenyl-(C 1 -C 4 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl-(C 1 -C 4 )-alkyl, R(9) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl or di-phenyl-(C 1 -C 5 )-alkyl, phenyl-(C 1 -C 4 )-alkanoyl or benzoyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl, pyrimidinyl or (C 1 -C 5 )-alkanoyl, R(10) denotes phenyl or phenyl-(C 1 -C 4 )-alkyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C1-C2)alkylenedioxy, F, Cl and hydroxyl, R(11) denotes hydrogen, hydroxyl or methoxy, or together with R(12) denotes a bond, and R(12) denotes hydrogen, or together with R(11) denotes a bond.
Claim 4
Dependent Claim 288 words
A compound I as claimed in claim 1, wherein R(1) denotes hydrogen, methyl, methoxy, fluorine or chlorine, R(1)' and R(1)" denote hydrogen, R(2) denotes hydrogen, methyl or ethyl, R(3) denotes hydrogen, methyl, ethyl, propyl, isopropyl, butyl, sec.-butyl, isobutyl, allyl, cyclopentyl, cyclohexyl, benzyl or phenethyl, the phenyl ring in each case being unsubstituted or substituted by methyl, methoxy, CF 3 , fluorine, chlorine, methylenedioxy or nitro, R(4) denotes hydrogen, methyl, methoxy, chlorine, nitro or hydroxyl, R(4)' denotes hydrogen, R(5) denotes hydrogen, hydroxyl or (C 1 -C 3 )-alkyl, m denotes 0 or 1, n denotes 0 or 1, p denotes 1, 2, 3 or 4 and R(6) denotes one of the following groups ##STR54## in which R(7) denotes hydrogen or methyl, R(8) denotes phenyl-(C 1 -C 4 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three radicals from the group consisting of methyl, methoxy, chlorine, methyenedioxy and hydroxyl, R(9) denotes hydrogen, straight-chain or branched (C 1 -C 10 )-alkyl, phenyl, phenyl-(C 1 -C 4 )-alkyl or di-phenyl-(C 1 -C 5 )-alkyl, phenyl-(C 1 -C 4 )-alkanoyl or benzoyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, (C 1 -C 2 )-alkylenedioxy, F, Cl, CF 3 and hydroxyl, or pyridyl, pyrimidinyl or (C 1 -C 5 )-alkanoyl, R(10) denotes phenyl or phenyl-(C1-C2)-alkyl, the phenyl radical in each case being unsubstituted or substituted by one, two or three radicals from the group consisting of methyl, methoxy, chlorine, methylenedioxy and hydroxyl, R(11) denotes hydrogen, hydroxyl or methoxy, or together with R(12) denotes a bond, and R(12) denotes hydrogen, or together with R(11) denotes a bond.
Claim 5
Dependent Claim 170 words
A compound as claimed in claim 1, wherein R(1) denotes hydrogen, methyl, methoxy, fluorine or chlorine, R(1)' and R(1)" denote hydrogen, R(2) denotes hydrogen or methyl, R(3) denotes methyl, ethyl, propyl, isopropyl, butyl, sec.-butyl, isobutyl, cyclopentyl, cyclohexyl or benzyl, unsubstituted or substituted by methoxy, methyl, fluorine, chlorine or nitro, R(4) denotes hydrogen, methoxy, methyl or chlorine, R(5) denotes hydrogen or hydroxyl, m denotes 0 or 1, n denotes 0 or 1, p denotes 1, 2, 3 or 4, R(6) denotes one of the following groups ##STR55## R(7) denotes methyl, R(8) denotes phenyl-(C 1 -C 4 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three radicals from the group consisting of methyl, methoxy, chlorine, methylenedioxy and hydroxyl, R(9) denotes phenyl-(C 1 -C 4 )-alkyl, the phenyl radical being unsubstituted or substituted by one, two or three radicals from the group consisting of (C 1 -C 2 )-alkylenedioxy and hydroxyl, or diphenyl-(C 1 -C 4 )-alkyl, the phenyl radicals being unsubstituted or substituted by chlorine, fluorine or methoxy.
Claim 6
Dependent Claim 59 words
an agent for the treatment of disturbances of the calcium balance in the body of a human or warmed-blooded animal, which agent comprises an amount effective for said treatment of at least one compound of formula I as claimed in claim 1 or a salt of said compound with a pharmaceutically acceptable acid together with a pharmaceutically acceptable excipient.
Claim 7
Dependent Claim 64 words
A method for the treatment of disturbances of the calcium balance in the body of a human or warm-blooded animal which comprises administering to said human or animal an amount effective for said treatment of at least one compound of formula I as claimed in claim 1 or a salt of said compound with a pharmaceutically acceptable acid together with a pharmaceutically acceptable excipient.

References Cited (Backward Citations)

GB1042638A Cited
NL6516320A Cited
DE2007468A1 Cited
US3551413A Cited
GB1305278A Cited
US4071520A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-10-18 1992-04-18 1992-10-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-10-18 1996-04-18 1996-10-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-10-18 2000-04-18 2000-10-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag